# Infectio Diagnostic (I.D.I.), Inc.

- Location (FDA's records): Hydes, MD
- FDA decisions: 2 (2004–2004): 2 510(k) clearances
- Product codes: NQX (2)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 6 (0 its own)
- Recalls linked to its devices: 4 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Oxoid, Ltd.: 1 (https://510kreport.com/company/oxoid)
- Remel Co.: 1 (https://510kreport.com/company/remel)

## Firms that cite its devices most
- Roche Molecular Systems, Inc.: 2 (https://510kreport.com/company/roche-molecular-systems)
- Bd Diagnostics (Geneohm Sciences, Inc.): 1 (https://510kreport.com/company/bd-diagnostics-geneohm-sciences)
- Bd Diagnostics (Geneohm Sciences Canada, Inc): 1 (https://510kreport.com/company/bd-diagnostics-geneohm-sciences-canada)
- Cepheid: 1 (https://510kreport.com/company/cepheid)
- bioMerieux, Inc.: 1 (https://510kreport.com/company/biomerieux)

## Its most-cited devices
- K042357: Idi-Mrsa Assay (2004), cited by 3
- K033415: Idi-Mrsa (2004), cited by 3

## Recent decisions
- K042357: Idi-Mrsa Assay (Oct 22, 2004)
- K033415: Idi-Mrsa (Mar 18, 2004)

Source page: https://510kreport.com/company/infectio-diagnostic-idi